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Abstract
The use of medicines is an essential aspect of treating disease. In this field, surveys that map the population’s use 
of medicines are of particular interest. The GEDA 2014/2015-EHIS study collected data on the use of medically 
prescribed and self-medicated drugs during the two weeks that preceded the survey. 58.9% of women and 52.0% 
of men reported that they had taken medically prescribed drugs during this period. 48.5% of women and 35.4% of 
men stated they had taken medication during this period that had not been prescribed by a doctor. The prevalence 
of the use of medically prescribed drugs and self-medication was higher among women than among men. Finally, 
the prevalence of the use of medically prescribed drugs increased significantly with age, whereas the prevalence of 
self-medication decreased with age.
  MEDICINES · SELF-MEDICATION · ADULTS · HEALTH MONITORING · GERMANY
Introduction
Medication is an essential to the treatment of health 
impairments, disorders and diseases. Alongside expens-
es for outpatient and inpatient services, expenditure on 
medicine is one of the major costs covered by statutory 
health insurers (SHIs). In 2016, German SHIs paid out 
EUR 38.5 billion for drug therapy [1]. These figures are sup-
plemented by the costs of medicines borne by the patients 
themselves through self-medication which amounted to 
around EUR 6.4 billion in 2015 [2]. A valid analysis of the 
consumption of medicines (the number of medicines 
sold) and use (the amount of medicine that is actually 
taken) is not only important from an economic point of 
view; it is a vital to assessments of the population’s health 
and to quantifying the use of medical services.
Since not all medically prescribed drugs are actually 
used [3] and only medically prescribed drugs are cov-
ered by SHI statistics [4], surveys that map use, includ-
ing self-medication by the population are of particular 
importance. Data from the health surveys conducted 
by the Robert Koch Institute (RKI) as part of the health 
monitoring framework can bridge the gap in the SHI 
data. The European Health Interview Survey (EHIS) 
provides harmonised health data that can be compared 
with those from other European Union member states 
(the EU, as well as Norway and Iceland). The EHIS 
questions on the use of medically prescribed drugs and 
over-the-counter, pharmacy-only medicines as well as 
those sold in chemists and supermarkets as over-the-
counter preparations were integrated into the German 
Health Update study (GEDA 2014/2015) conducted by 
the RKI. The GEDA 2014/2015-EHIS study, therefore, 
provides up-to-date data on the use of medicines in 
Germany.
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man Health Update: New data for Germany and Europe 
in issue 1/2017 of the Journal of Health Monitoring. This 
study describes prevalences with 95% confidence inter-
vals (95% CI). A statistically significant difference 
between groups is assumed when p-values are lower 
than 0.05 (after taking weighting and the survey design 
into account). The results presented here are purely 
descriptive and do not enable conclusions to be drawn 
as to whether other factors may explain the differences 
that were identified between the groups.
Results and discussion
More than half (55.5%) of all study participants (58.9% 
of women and 52.0% of men) reported that they had 
taken medically prescribed drugs during the two weeks 
prior to the study (Table 1).
Although the observation period for GEDA 2014/2015-
EHIS was longer than the period analysed for the 2008-
2011 German Health Interview and Examination Survey 
for Adults (DEGS1) – two weeks instead of one week – 
GEDA 2014/2015-EHIS identified a significantly lower 
prevalence among women than the rate found by DEGS1 
(58.9% instead of 71.3 %) [6]. However, GEDA 2014/2015-
EHIS identified a higher prevalence among men (52.0% 
instead of 46.1%) [6]. The differences among women 
can probably be explained by the fact that GEDA 
2014/2015-EHIS did not record the use of the pill or other 
contraceptive hormonal preparations. The higher rate 
identified among men is probably due to the longer 
observation window used in GEDA 2014/2015-EHIS. 
Most importantly, however, DEGS1 and GEDA 2014/2015-
EHIS studied different age groups (18 to 79 and 18 or 
Indicators
The prevalence of current use is represented by the fig-
ures on the use of medication that occurred in the two 
weeks prior to the survey. The data was divided between 
two indicators as a distinction was made between the 
use of medically prescribed drugs and over-the-counter 
medicines. Data on these two indicators were collected 
as part of the GEDA 2014/2015-EHIS study using a 
self-administered questionnaire completed on paper or 
online. The questionnaire asked: 1) ‘Have you taken any 
medications prescribed by a doctor in the last 2 weeks? 
(Do not include the pill or other hormonal contraceptive 
preparations.)’ and 2) ‘Have you taken any medications, 
herbal remedies or vitamins that were not prescribed by 
a doctor during the last 2 weeks? (Do not include the 
pill or other hormonal contraceptive preparations.)’
The analyses of prescribed drugs are based on data 
from 23,898 participants aged 18 or over (13,087 women; 
10,811 men) with valid data on the use of medicines. The 
analyses of self-medication are based on information 
from 23,848 individuals (13,063 women; 10,785 men). 
The calculations were carried out using a weighting fac-
tor that corrected the sample for deviations from the 
population structure (as of 31 December 2014) in terms 
of gender, age, district type and level of education. The 
district type reflects the degree of urbanisation and cor-
responds to the regional distribution in Germany. The 
International Standard Classification of Education 
(ISCED) was used to classify the educational and occu-
pational qualifications [5]. A detailed description of the 
methodology used for GEDA 2014/2015-EHIS can be 
found in Lange et al. 2017 [6] as well as in the article Ger-
GEDA 2014/2015-EHIS
Data holder: Robert Koch Institute
Aims: To provide reliable informa tion 
about the population’s health status, 
health-related behaviour and health care  
in Germany, with the possibility of a  
European comparison 
Method: Questionnaires completed on 
paper or online
Population: People aged 18 years and above 
with permanent residency in Germany
Sampling: Registry office sample; randomly 
selected individuals from 301 communities 
in Germany were invited to participate
Participants: 24,016 people (13,144 women; 
10,872 men)
Response rate: 26.9%
Study period: November 2014 - July 2015
Data protection: This study was undertaken 
in strict accordance with the data protection 
regulations set out in the German Federal 
Data Protection Act and was approved by 
the German Federal Commissioner for Data 
Protection and Freedom of Information.  
Participation in the study was voluntary. 
The participants were fully informed about 
the study’s aims and content, and about 
data protection. All participants provided 
written informed consent.
 
More information in German is available at 
www.geda-studie.de
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However, DEGS1 demonstrates that over 40% of 70- to 
79-year-old adults took at least five medically prescribed 
drugs in the seven days prior to the survey [7]. In the light 
of the potential risks of polypharmacy [8-11], this result 
demonstrates the need for further research. A direct com-
parison of the age-specific prevalences identified by 
GEDA 2014/2015-EHIS and DEGS1 cannot be undertaken, 
as the studies targeted different age groups [7].
Significant differences in the use of medically pre-
scribed drugs between the genders in the 18-to-29, 30-to-
44, and 45-to-64 age groups were identified from the 
data collected for GEDA 2014/2015-EHIS. The prevalence 
was higher among women than men, but converged 
above) and also differed on the way in which they imple-
mented data collection.
GEDA 2014/2015-EHIS demonstrates that the use of 
medically prescribed drugs increases with age: in the 
youngest age group (18 to 29), 33.8% of women and 21.3% 
of men reported that they had taken medicines during 
the past two weeks, whereas prevalence rates for those 
aged 65 or above were much higher (87.1% among 
women and 86.3% among men, Table 1). This increase 
has also been demonstrated by other studies [7] and is 
attributable to the fact that the prevalence of (chronic) 
diseases rises with age. GEDA 2014/2015-EHIS did not 
record the actual number of medicines that were taken. 
Table 1 
Prevalence of the use of medically prescribed 
medicines in the last 2 weeks according 
to gender, age and educational level 
(n=13,087 women, n=10,811 men) 
Source: GEDA 2014/2015-EHIS
Women % (95% CI)
Women (total) 58.9 (57.8-60.0)
18-29 years 33.8 (31.4-36.4)
Low education 40.5 (34.3-46.9)
Medium education 33.1 (29.9-36.5)
High education 27.5 (23.3-32.2)
30-44 years 38.7 (36.6-40.8)
Low education 41.7 (34.9-48.9)
Medium education 39.3 (36.5-42.1)
High education 35.4 (32.1-38.8)
45-64 years 61.4 (59.8-63.1)
Low education 67.0 (62.5-71.3)
Medium education 61.5 (59.4-63.5)
High education 56.2 (53.4-58.8)
≥ 65 years 87.1 (85.5-88.5)
Low education 88.7 (86.5-90.7)
Medium education 85.9 (83.4-88.0)
High education 85.9 (82.7-88.7)
Total (women and men) 55.5 (54.7 – 56.4)
CI=confidence interval
Men % (95% CI)
Men (total) 52.0 (50.8-53.2)
18-29 years 21.3 (18.8-24.1)
Low education 25.6 (20.1-32.1)
Medium education 20.1 (17.1-23.5)
High education 19.0 (14.2-24.9)
30-44 years 31.9 (29.4-34.4)
Low education 36.9 (29.2-45.4)
Medium education 35.3 (32.1-38.7)
High education 22.9 (20.2-25.9)
45-64 years 58.5 (56.6-60.4)
Low education 67.0 (62.2-71.5)
Medium education 59.7 (56.9-62.5)
High education 53.5 (50.9-56.0)
≥ 65 years 86.3 (84.9-87.7)
Low education 86.3 (82.6-89.3)
Medium education 87.0 (84.7-89.1)
High education 85.2 (82.7-87.4)
Total (women and men) 55.5 (54.7-56.4)
i
More than half of the study 
participants took medication 
that had been prescribed by 
a doctor during the two 
weeks prior to the study.
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been previously demonstrated by DEGS1 and the Ger-
man National Health Interview and Examination Survey 
1998 (GNHIES98, 1997-1999). These studies show that 
self-medication was associated with high levels of social 
status among both genders [7, 12, 13]. Similar results 
were obtained from a population-based study in Spain, 
where self-medication in the case of acute diseases was 
also associated with higher levels of education [14].
There are only slight differences between the federal 
states in terms of the use of medicines (Data not shown). 
Compared to the national average, significantly lower 
prevalences of the use of medically prescribed drugs are 
found among women in Hamburg, Bavaria and Baden- 
Württemberg, as well as among men in Bremen and Ber-
lin. Higher prevalences were identified among women 
and men in Saarland, among women in Brandenburg 
and among men in Saxony-Anhalt. Significantly lower 
prevalences of self-medication were observed in Thur-
ingia and Saxony-Anhalt among both genders, among 
women in Mecklenburg-Western Pomerania and among 
men in Baden-Württemberg. Higher prevalences were 
only observed among women in Bavaria, Rhineland-Pa-
latinate, and Baden-Württemberg. Data on the regional 
distribution of the use of medicines according to federal 
state are available from the Information System of the 
Federal Health Monitoring (www.gbe-bund.de). With 
regard to prescription medicines, demographic factors 
such as age, gender, the social situation and the mor-
bidity spectrum of each federal state are important, but 
not the only reasons that explain regional differences 
[15-17]. Differentiated data on the self-medication of 
non-medically prescribed drugs are, as yet, only availa-
among people aged above 44. DEGS1 also observed that 
gender-specific differences tend to smooth out in older 
age [7].
Apart from people aged 65 or above, GEDA 2014/2015-
EHIS found that women and men from the lower edu-
cational group had a higher prevalence of using medi-
cally prescribed drugs than those from the upper 
educational group. The differences were significant in 
women aged 18 to 29 and 45 to 64, as well as in men 
aged 30 to 44 and 45 to 64 (Table 1). DEGS1 also iden-
tified a higher use of medicines among people with a 
low socioeconomic status, and in particular among 
women [7].
Almost half (48.5%) of women and more than one-
third (35.4%) of men reported that they had taken med-
ications that had not been medically prescribed, in other 
words, that they had self-medicated during the two weeks 
that preceded the GEDA study (Table 2). As with medi-
cally prescribed drugs, the prevalence of self-medication 
among women was significantly higher than among men. 
This difference can be observed in all age groups. In con-
trast to the age-specific increase in the use of medically 
prescribed drugs, self-medication tends to decrease with 
age. Self-medication was much less common in people 
aged 45 or above, than among under-45s. In terms of 
educational status, prevalence rates were higher for the 
upper educational group than for the lower educational 
group. However, differences are significant only among 
women aged 30 or over and among men aged 45 to 64 
(Table 2). The increase in self-medication with rising edu-
cational attainment, which is often associated with a 
higher professional status and higher income, has also 
Almost half of the women 
and more than a third of  
the men surveyed took  
medication that had not 
been prescribed by a doctor 
within the two weeks prior  
to the study.
Although the prevalence of 
the use of medically 
prescribed drugs increases 
significantly with age, the 
prevalence of self-medication 
tends to decrease with age.
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evance to public health with regard to both cost and 
health issues. However, it is not only medically pre-
scribed drugs that need to be considered; studies also 
need to cover everything that is used for self-medication. 
The importance of self-medication is underscored by an 
international comparison that places Germany as one 
of the table leaders [18].
ble from GEDA 2014/2015-EHIS. The analysis of the dif-
ferences between the old German federal states and the 
new federal states undertaken as part of GNHIES98 
showed a much lower level of self-medication among 
people living in the new federal states [13].
Medicines are essential to health care. This Fact sheet, 
along with other contributions to this issue (Fact sheets 
on the utilization of outpatient and inpatient medical 
care, physiotherapy, and the Focus on the utilization of 
psychotherapeutic and psychiatric treatment), provides 
an overview of significant aspects of the utilization of 
health care by adults in Germany. Continuous monitor-
ing of the consumption of medicines is of particular rel-
Table 2 
Prevalence of the use of non-medically 
prescribed medicines (self-medication) over the 
past 2 weeks according to gender, 
age and educational level 
(n=13,063 women, n=10,785 men) 
Source: GEDA 2014/2015-EHIS
Women % (95% Cl)
Women total 48.5 (47.3-49.6)
18-29 years 51.3 (48.7-53.8)
Low education 48.5 (42.1-55.0)
Medium education 51.5 (48.3-54.8)
High education 53.7 (48.7-58.7)
30-44 years 53.1 (51.1-55.1)
Low education 42.5 (35.8-49.5)
Medium education 54.5 (51.8-57.2)
High education 56.2 (53.0-59.3)
45-64 years 48.7 (46.8-50.6)
Low education 43.0 (38.6-47.6)
Middle education 48.8 (46.5-51.2)
High education 53.4 (50.6-56.2)
≥65 years 42.7 (40.5-44.9)
Low education 39.7 (36.2-43.3)
Middle education 43.8 (40.5-47.2)
High education 49.9 (44.3-55.5)
Total (women and men) 42.1 (41.2-43.0)
CI=confidence interval
Men % (95% Cl)
Men total 35.4 (34.2-36.6)
18-29 years 36.1 (33.1-39.3)
Low education 37.0 (30.5-44.0)
Medium education 34.4 (30.7-38.3)
High education 42.1 (36.0-48.4)
30-44 years 39.5 (36.9-42.2)
Low education 37.4 (29.5-46.1)
Medium education 38.9 (35.4-42.6)
High education 41.3 (37.6-45.1)
45-64 years 33.7 (31.9-35.4)
Low education 27.4 (23.3-31.9)
Middle education 32.3 (29.9-34.7)
High education 38.3 (35.8-40.9)
≥65 years 33.5 (31.6-35.6)
Low education 31.5 (27.0-36.4)
Middle education 32.1 (29.2-35.1)
High education 37.5 (34.0-41.1)
Total (women and men) 42.1 (41.2-43.0)
i
With the exception of  
people aged 65 or above, the 
prevalence of the use of 
medically prescribed drugs is 
higher among women than 
in men; the prevalence of 
self-medication is higher 
among women of all ages.
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